HIGHVISTA STRATEGIES LLC – Aclaris Therapeutics, Inc. Transaction History
HIGHVISTA STRATEGIES LLC portfolio value:
$3.42M
portfolio value
HIGHVISTA STRATEGIES LLC quarter portfolio value change:
+12.75%
quarter
Aclaris Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +0.13% | 290 shares | 391K | $15.74 | 217.81K |
| Q2 2022 | share | Increase | +37.46% | 59.28K shares | 309K | $13.96 | 217.52K |
| Q1 2022 | share | Increase | +41.09% | 46.08K shares | 1.09M | $17.24 | 158.24K |
| Q4 2021 | share | Increase | +20.60% | 19.16K shares | -44K | $14.33 | 112.16K |
| Q3 2021 | share | Increase | +134.40% | 53.32K shares | 978K | $18 | 93K |
| Q2 2021 | share | Increase | 0.00% | 39.67K shares | 697K | $17.56 | 39.67K |